Registro Colombiano de Enfermedades Glomerulares (Reglocol): informe preliminar
| datacite.rights | http://purl.org/coar/access_right/c_abf2 | |
| dc.contributor.author | Aroca-Martinez, Gustavo | |
| dc.contributor.author | Figueroa Millán , Christian Camilo | |
| dc.contributor.author | Daza, Jose Lucas | |
| dc.contributor.author | Cadena Bonfanti, Andres Angélo | |
| dc.contributor.author | Pérez Jiménez, Valentina | |
| dc.contributor.author | LASSO LATORRE, KAREN GISELLE | |
| dc.contributor.author | Torres Saltarín, Jaime José | |
| dc.contributor.author | Cotes Araujo, Luis Andrés | |
| dc.contributor.author | Puche Carrascal, Eduardo | |
| dc.contributor.author | Hernandez Agudelo, Sandra | |
| dc.contributor.author | Pérez Padilla, Rafael | |
| dc.contributor.author | Peña Vargas , William arturo | |
| dc.contributor.author | Castillo Parodi, Luis | |
| dc.contributor.author | Riascos, William | |
| dc.contributor.author | Castro Ahumada, Eddie | |
| dc.contributor.author | Ramirez-Marmolejo, Roberto | |
| dc.contributor.author | AHUMADA NOLASCO, GUSTAVO | |
| dc.contributor.author | Rodriguez, Liliana | |
| dc.contributor.author | Soto-Morón, Andrés | |
| dc.contributor.author | Vizcaino figueroa, Zoyla | |
| dc.contributor.author | Natib, Danna | |
| dc.contributor.author | Aroca Vidal, María | |
| dc.contributor.author | Fontalvo Avila, Nicoll | |
| dc.contributor.author | CAMARGO RODRIGUEZ, KANERY MARCELA | |
| dc.contributor.author | Vasquez Obeso, Esteban De Jesus | |
| dc.date.accessioned | 2025-10-30T21:21:31Z | |
| dc.date.available | 2025-10-30T21:21:31Z | |
| dc.date.issued | 2025 | |
| dc.description.abstract | Contexto: las enfermedades glomerulares son una causa relevante de morbilidad renal y se clasifican en primarias y secundarias. En América Latina predominan las formas secundarias asociadas a lupus. En Colombia, el Registro REGLOCOL busca caracterizar su perfil clínico, histológico y terapéutico para fortalecer la investigación en nefrología. Objetivo: describir las características demográficas, clínicas e histopatológicas de los pacientes incluidos en la fase preliminar del Registro Colombiano de Enfermedades Glomerulares (Reglocol). Métodos: se realizó un estudio descriptivo de corte transversal que analizó 900 reportes de biopsia renal procedentes de 11 centros de nefrología en Colombia, recolectados entre 2010 y 2025. Se obtuvieron variables demográficas, clínicas e histopatológicas a partir de formularios estandarizados. Se aplicó estadística descriptiva y los resultados se expresaron en frecuencias, medias y medianas con rangos intercuartílicos. Resultados: de las 900 biopsias revisadas, 864 cumplieron criterios de inclusión. Las glomerulopatías primarias representaron el 70,7 % de los casos, mientras que las secundarias constituyeron el 29,3 %. Los diagnósticos más frecuentes fueron nefritis lúpica (22,8 %), glomeruloesclerosis focal y segmentaria (22,1 %), glomerulonefritis membranoproliferativa (14,1 % y nefropatía por inmunoglobulina A (IgA) (12,0 %). Se observó predominio del sexo femenino (56,8 %), etnia mestiza (88,5 %) y edades entre 30 y 59 años (42,4 %). El síndrome nefrótico (39,8 %) y la hipertensión arterial (35,3 %) fueron las presentaciones clínicas más comunes. La mayor concentración de casos se registró en la región Caribe, correspondiente a los centros participantes. Conclusiones: los hallazgos preliminares del Reglocol evidenciaron que las glomerulopatías en Colombia afectan predominantemente a mujeres en edad productiva, siendo la nefritis lúpica y la glomeruloesclerosis focal y segmentaria las entidades más prevalentes. Reglocol representa un avance significativo en la caracterización nacional de las enfermedades glomerulares y constituye la base para futuros estudios multicéntricos sobre determinantes epidemiológicos, genéticos y ambientales de la enfermedad renal en América Latina. | spa |
| dc.description.abstract | Background: Glomerular diseases are a significant cause of renal morbidity and are classified as primary or secondary. In Latin America, secondary forms associated with lupus are predominant. In Colombia, the REGLOCOL Registry aims to characterize their clinical, histological, and therapeutic profiles to strengthen nephrology research. Objective: To describe the demographic, clinical, and histopathological characteristics of patients included in the preliminary phase of the Colombian Registry of Glomerular Diseases (REGLOCOL). Methods: A descriptive cross-sectional analysis of 900 biopsy reports from 11 nephrology centers across Colombia was conducted between 2010 and 2025. Clinical, demographic, and histopathological data were extracted from standardized forms. Descriptive statistics were used to summarize the data, which are presented as frequencies, means, and medians with interquartile ranges. Results: Of the 900 biopsies reviewed, 864 met inclusion criteria. Primary glomerulopathies accounted for 70.7 % of cases, while secondary forms represented 29.3 %. The most frequent diagnoses were lupus nephritis (22.8 %), focal and segmental glomerulosclerosis (22.1 %), membranoproliferative glomerulonephritis (14.1 %), and IgA nephropathy (12 %). The cohort was predominantly female (56.8 %), of mestizo ethnicity (88.5 %), and aged 30-59 years (42.4 %). The most common clinical presentation was nephrotic syndrome (39.8 %), followed by arterial hypertension (35.3 %). Regional distribution revealed a higher concentration of cases in the Caribbean region, which corresponded to the larger number of participating centers located in that region. Conclusions: Preliminary findings from REGLOCOL reveal that glomerular diseases in Colombia predominantly affect women of productive age, with lupus nephritis and focal and segmental glomerulosclerosis as the leading entities. REGLOCOL represents a milestone in the national characterization of glomerular pathology and establishes a foundation for future multicenter studies aimed at understanding epidemiological, genetic, and environmental determinants of kidney disease in Latin America. | eng |
| dc.format.mimetype | ||
| dc.identifier.citation | Aroca Martínez G, Figueroa Millan C, Daza JL, Cadena Bonfanti A, Pérez Jiménez V, Lasso Latorre K, et al. Registro Colombiano de Enfermedades Glomerulares (Reglocol): informe preliminar. Rev. Colomb. Nefrol. 2025; 12(3), e1065. https://doi.org/10.22265/acnef.12.3.1065 | |
| dc.identifier.doi | https://doi.org/10.22265/acnef.12.3.1065 | |
| dc.identifier.issn | 25005006 | |
| dc.identifier.issn | 23897708 (en línea) | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12442/17074 | |
| dc.identifier.url | https://revistanefrologia.org/index.php/rcn/article/view/1065 | |
| dc.language.iso | spa | |
| dc.publisher | Asociación Colombiana de Nefrología e Hipertensión Arterial | spa |
| dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International | eng |
| dc.rights.accessrights | info:eu-repo/semantics/openAccess | |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | |
| dc.source | Revista Colombiana de Nefrología | spa |
| dc.source | Vol. 12, Núm. 3, (2025) | spa |
| dc.subject | Glomerulopatías | spa |
| dc.subject | Nefritis lúpica | spa |
| dc.subject | Glomeruloesclerosis focal y segmentaria | spa |
| dc.subject | Biopsia renal | spa |
| dc.subject | Epidemiología | spa |
| dc.subject.keywords | Glomerulopathies | eng |
| dc.subject.keywords | Lupus nephritis | eng |
| dc.subject.keywords | Focal segmental glomerulosclerosis | eng |
| dc.subject.keywords | Kidney biopsy | eng |
| dc.subject.keywords | Epidemiology | eng |
| dc.title | Registro Colombiano de Enfermedades Glomerulares (Reglocol): informe preliminar | spa |
| dc.title.translated | Colombian Registry of Glomerular Diseases (Reglocol): preliminary report | eng |
| dc.type.driver | info:eu-repo/semantics/article | |
| dc.type.spa | Artículo científico | |
| dcterms.references | Wang X, Liu Z, Yi N, Li L, Ma L, Yuan L, et al. The global burden of chronic kidney disease due to glomerulonephritis: trends and predictions. Int Urol Nephrol. 2025;57(8):2613-24. https://doi.org/10.1007/s11255-025-04440-2 | spa |
| dcterms.references | Rodelo-Ceballos J, Chávez-Gómez WF, Taborda-Murillo A, Arias LF. Epidemiology of glomerular diseases in a Colombian population. Rev Esp Patol. 2025;58(3):100813. https:// doi.org/10.1016/j.patol.2025.100813 | spa |
| dcterms.references | López-Gómez JM, Rivera F. Registro de glomerulonefritis de la Sociedad Española de Nefrología en 2019: pasado, presente y nuevos retos. Nefrología. 2020;40(4): 371-383. https:// doi.org/10.1016/j.nefro.2020.04.012 | spa |
| dcterms.references | Ghaddar M, Canney M, Barbour SJ. IgA nephropathy: epidemiology and disease risk across the world. Semin Nephrol. 2024;44(5):151564. https://doi.org/10.1016/j.semnephrol. 2025.151564 | spa |
| dcterms.references | do Nascimento Costa DM, Valente LM, da Cruz Gouveia PA, Sarinho FW, Fernandes GV, Gomes de Mattos Cavalcante MA, et al. Comparative analysis of primary and secondary glomerulopathies in the northeast of Brazil: data from the Pernambuco Registry of Glomerulopathies. J Bras Nefrol. 2017;39(1):29-35. https://doi.org/10.5935/0101-2800.20170005 | spa |
| dcterms.references | Valdez-Yánez G, Hernández-Pacheco J, Arellán-Bravo L, Velásquez-Castillo P, Matias- Tasayco V, Espinoza-Verástegui J, et al. Glomerulonefritis por biopsia en población atendida en el Hospital Nacional Dos de Mayo. Lima, 2007-2016. An Fac Med. 2018;79(2):115-8. http://dx.doi.org/10.15381/anales.v79i2.14936 | spa |
| dcterms.references | Garau M, Cabrera J, Ottati G, Caorsi H, González Martínez F, Acosta N, et al. Temporal trends in biopsy-proven glomerular disease in Uruguay, 1990-2014. PLoS One. 2018;13(10):e0206637. https://doi.org/10.1371/journal.pone.0206637 | spa |
| dcterms.references | Kidney Disease: Improving Global Outcomes (KDIGO) ANCAVasculitisWork Group. KDIGO 2024 Clinical Practice Guideline for the Management of Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis. Kidney Int. 2024;105(3):S71-116. https://doi.org/ 10.1016/j.kint.2023.10.008 | spa |
| dcterms.references | Noronha IL, Ramalho RJ, Costa de Oliveira CM, Bahiense-Oliveira M, Marques Barbosa FA, Barros Neto JR, et al. Implementation and first report of the Brazilian Kidney Biopsy Registry. PLoS One. 2025;20(2):e0312410. https://doi.org/10.1371/journal.pone.0312410 | spa |
| dcterms.references | Durán CE, Ramírez A, Posada JG, Schweineberg J, Mesa L, Pachajoa H, et al. Prevalence of APOL1 risk variants in Afro-descendant patients with chronic kidney disease in a Latin American country. Int J Nephrol. 2019;2019:7076326. https://doi.org/10.1155/2019/7076326 | spa |
| dcterms.references | Nadkarni GN, Gignoux CR, Sorokin EP, Daya M, Rahman R, Barnes KC, et al.Worldwide frequencies of APOL1 renal risk variants. N Engl J Med. 2018;379(26):2571-2. https://doi.org/ 10.1056/nejmc1800748 | spa |
| dcterms.references | Rodelo J, Aguirre L, Ortegón K, Ustáriz J, Calderón L, Taborda A, et al. Predicting kidney outcomes among Latin American patients with lupus nephritis: the prognostic value of interstitial fibrosis and tubular atrophy and tubulointerstitial inflammation. Lupus. 2023;32(3):411-23. https://doi.org/10.1177/09612033231151597 | spa |
| dcterms.references | Ghaddar Glassock RJ. An Expert Opinion on Current and Future Treatment Approaches in IgA Nephropathy. Advances in Therapy. 2025;42:2545-2558. https://doi.org/10.1007/ s12325-025-03187-7 | spa |
| dcterms.references | Ubara Y, Sawa N, Yamanouchi M, Kono K, Ohashi K. New interpretation of diabetic nephropathy or diabetic kidney disease from kidney biopsy: review article. Clin Exp Nephrol. 2025;29(7):875-87. https://doi.org/10.1007/s10157-025-02661-4 | spa |
| dcterms.references | Bermejo S, González E, López-Revuelta K, Ibernon M, López D, Martín-Gómez A, et al. A predictive model of non-diabetic kidney disease in patients with diabetes mellitus and chronic kidney disease. A Spanish multi-center study. Nefrologia. 2025;45(5):360- 8. https:// doi.org/10.1016/j.nefroe.2025.04.004 | spa |
| dcterms.references | Jiang M, Chen H, Luo J, Chen J, Gao L, Zhu Q. Characterization of diabetic kidney disease in 235 patients: clinical and pathological insights with or without concurrent non-diabetic kidney disease. BMC Nephrol. 2025;26(1):29. https://doi.org/10.1186/ s12882-024-03931-1 ↑Ver página 14 | spa |
| oaire.version | info:eu-repo/semantics/publishedVersion |

